Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas
Finch Therapeutics Group, Inc., a... read more
Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas
Finch Therapeutics Group, Inc., a... read more
iBio filed for a $30 million offering on 8/29/19. iBio is a contract development and manufacturing organization (CDMO) that specializes in plant-based expression biologics. The company trades on... read more
Exagen filed the paperwork for a $57 Million IPO on 8/23/19. The company provides diagnostics to aid in the man"agement of autoimmune diseases. Exagen will trade on NASDAQ under the symbol "XGN."... read more
Novalis LifeSciences, an investment and advisory firm for the Life Science industry, announced today that it has raised $85M in capital for its first fund - Novalis LifeSciences Investments I, L.P... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,